The exposition of osteoblast-like cells to sera of RA patients treated with TNF-α inhibitors has been associated to a reduced synthesis of IL-6, a cytokine directly responsible for arthritis-related bone loss [42]. Here, IL6 is linked to rheumatoid arthritis.